182 related articles for article (PubMed ID: 32222367)
41. A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Hwang DG; Schanzlin DJ; Rotberg MH; Foulks G; Raizman MB;
Br J Ophthalmol; 2003 Aug; 87(8):1004-9. PubMed ID: 12881345
[TBL] [Abstract][Full Text] [Related]
42. In vitro efficacy of povidone iodine and hydroxyethyl cellulose, alone and in combination, against common feline ocular pathogens.
Pennington MR; Capriotti JA; Van de Walle GR
Vet J; 2018 Nov; 241():38-41. PubMed ID: 30340658
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
[TBL] [Abstract][Full Text] [Related]
44. A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitis.
Yee RW; Tepedino M; Bernstein P; Jensen H; Schiffman R; Whitcup SM;
Curr Med Res Opin; 2005 Mar; 21(3):425-31. PubMed ID: 15811211
[TBL] [Abstract][Full Text] [Related]
45. Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis.
Adenis JP; Colin J; Verin P; Saint-Blancat P; Malet F
Eur J Ophthalmol; 1995; 5(2):82-7. PubMed ID: 7549447
[TBL] [Abstract][Full Text] [Related]
46. Prospective, Randomized Clinical Trial of Povidone-Iodine 1.25% Solution Versus Topical Antibiotics for Treatment of Bacterial Keratitis.
Isenberg SJ; Apt L; Valenton M; Sharma S; Garg P; Thomas PA; Parmar P; Kaliamurthy J; Reyes JM; Ong D; Christenson PD; Del Signore M; Holland GN
Am J Ophthalmol; 2017 Apr; 176():244-253. PubMed ID: 27984024
[TBL] [Abstract][Full Text] [Related]
47. Management of giant fornix syndrome with irrigation with povidone-iodine.
Karim R; Mandal N; Tuft S
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30317197
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
Bremond-Gignac D; Nezzar H; Bianchi PE; Messaoud R; Lazreg S; Voinea L; Speeg-Schatz C; Hartani D; Kaercher T; Kocyla-Karczmarewicz B; Murta J; Delval L; Renault D; Chiambaretta F;
Br J Ophthalmol; 2014 Jun; 98(6):739-45. PubMed ID: 24526744
[TBL] [Abstract][Full Text] [Related]
49. Clinical trial of povidone-iodine (Betadine) versus placebo in the pretreatment of corneal ulcers.
Gregori NZ; Schiffman JC; Miller DM; Alfonso EC
Cornea; 2006 Jun; 25(5):558-63. PubMed ID: 16783144
[TBL] [Abstract][Full Text] [Related]
50. Comment on: A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
Kanclerz P; Myers WG
Am J Ophthalmol; 2020 Oct; 218():353. PubMed ID: 32826035
[No Abstract] [Full Text] [Related]
51. Reply to Comment on: A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
Ta CN; Raizman MB; Gross RD; Joshi S; Mallick S; Wang Y; Segal B
Am J Ophthalmol; 2020 Oct; 218():354. PubMed ID: 32826036
[No Abstract] [Full Text] [Related]
52. Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
Baiza-Durán L; Olvera-Montaño O; Mercado-Sesma AR; Oregon-Miranda AA; Lizárraga-Corona A; Ochoa-Tabares JC; Pérez-Balbuena AL; Montoya-Sánchez IM; Saucedo-Rodríguez LR; Mora-González A; Gómez-Bastar PA; Villanueva-Najera MA; Sandoval-Delgadillo LI; González-Lomelí M; Páez-Garza JH; Orozco-Carroll M; Casillas-Magallanes M
J Ocul Pharmacol Ther; 2018 Apr; 34(3):250-255. PubMed ID: 29624493
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery.
Li B; Nentwich MM; Hoffmann LE; Haritoglou C; Kook D; Kampik A; Sheng M; Miño de Kaspar H
J Cataract Refract Surg; 2013 Jul; 39(7):994-1001. PubMed ID: 23680628
[TBL] [Abstract][Full Text] [Related]
54. Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6.
DeCory HH; Sanfilippo CM; Proskin HM; Blondeau JM
PLoS One; 2020; 15(8):e0237603. PubMed ID: 32841261
[TBL] [Abstract][Full Text] [Related]
55. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis.
Schuhman G; Vidic B
J Hosp Infect; 1985 Mar; 6 Suppl A():173-5. PubMed ID: 2860164
[TBL] [Abstract][Full Text] [Related]
56. The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery.
Mendivil Soto A; Mendivil MP
Am J Ophthalmol; 2001 Mar; 131(3):293-300. PubMed ID: 11239859
[TBL] [Abstract][Full Text] [Related]
57. Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.
Tauber S; Cupp G; Garber R; Bartell J; Vohra F; Stroman D
Adv Ther; 2011 Jul; 28(7):566-74. PubMed ID: 21681652
[TBL] [Abstract][Full Text] [Related]
58. Comparative evaluation of antimicrobial activity of polyvinylpyrrolidone (PVP)-iodine versus topical antibiotics in cataract surgery.
Chaudhary U; Nagpal RC; Malik AK; Kumar A
J Indian Med Assoc; 1998 Jul; 96(7):202-4. PubMed ID: 9830286
[TBL] [Abstract][Full Text] [Related]
59. Ocular infection investigations in Cairo's waste disposal sites. PVP-iodine treatment trials.
Schabus V; Sixl W; Sixl-Voigt B; Marth E; Köck M
Geogr Med Suppl; 1989; 3():103-12. PubMed ID: 2583496
[TBL] [Abstract][Full Text] [Related]
60. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
Protzko E; Bowman L; Abelson M; Shapiro A;
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3425-9. PubMed ID: 17652708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
